<div id="readability-page-1"><p>New York State Common Retirement Fund lifted its stake in  Genpact Limited (NYSE:G - Free Report) by 25.3% in the second quarter, according to its most recent filing with the Securities &amp; Exchange Commission. The firm owned 227,915 shares of the business services provider's stock after purchasing an additional 46,080 shares during the quarter. New York State Common Retirement Fund owned 0.13% of Genpact worth $10,031,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p><ul><li>These 2 Energy Titans Just Scored Major Wins to Close Out November</li></ul><p>Several other institutional investors and hedge funds have also recently bought and sold shares of G. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of  Genpact by 2.5% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 9,890 shares of the business services provider's stock worth $454,000 after buying an additional 240 shares during the period.  Sylvest Advisors LLC lifted its position in shares of  Genpact by 1.5% in the 2nd quarter. Sylvest Advisors LLC now owns 17,902 shares of the business services provider's stock valued at $788,000 after acquiring an additional 258 shares in the last quarter.  Louisiana State Employees Retirement System lifted its position in shares of  Genpact by 0.7% in the 2nd quarter. Louisiana State Employees Retirement System now owns 45,300 shares of the business services provider's stock valued at $1,994,000 after acquiring an additional 300 shares in the last quarter.  Petrus Trust Company LTA boosted its stake in  Genpact by 2.2% in the 1st quarter. Petrus Trust Company LTA now owns 14,390 shares of the business services provider's stock worth $725,000 after purchasing an additional 305 shares during the period.  Finally, Main Management ETF Advisors LLC grew its position in  Genpact by 1.7% during the 2nd quarter. Main Management ETF Advisors LLC now owns 20,524 shares of the business services provider's stock worth $903,000 after purchasing an additional 336 shares in the last quarter. Institutional investors and hedge funds own  96.03% of the company's stock. </p><h2>Insider Buying and Selling at Genpact</h2><p>In other Genpact news, CEO Balkrishan Kalra sold 55,000 shares of the firm's stock in a transaction dated Thursday, September 11th. The stock was sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the transaction, the chief executive officer directly owned 295,246 shares in the company, valued at $12,801,866.56. This trade represents a 15.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at the SEC website. Also, SVP Sameer Dewan sold 26,531 shares of the company's stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $44.70, for a total value of $1,185,935.70. Following the sale, the senior vice president owned 62,617 shares of the company's stock, valued at approximately $2,798,979.90. This trade represents a 29.76% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 161,183 shares of company stock worth $6,970,760 over the last quarter. Company insiders own  3.07% of the company's stock. </p><h2>Genpact Stock Performance</h2><ul><li>JPMorgan and Goldman Upgrade MP Materials Amid Defense-Driven Demand Outlook</li></ul><p>Shares of G stock opened at $45.97 on Friday. Genpact Limited has a fifty-two week low of $37.49 and a fifty-two week high of $56.76. The stock's 50-day moving average is $41.70 and its two-hundred day moving average is $43.05. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.51 and a quick ratio of 1.51. The firm has a market cap of $7.93 billion, a P/E ratio of 14.83, a PEG ratio of 1.45 and a beta of 0.76. </p><p>Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings results on Thursday, November 6th. The business services provider reported $0.97 EPS for the quarter, beating the consensus estimate of $0.90 by $0.07. Genpact had a return on equity of 22.55% and a net margin of 11.01%.The business had revenue of $1.29 billion during the quarter, compared to analysts' expectations of $1.27 billion. During the same quarter in the previous year, the business posted $0.85 EPS. The firm's quarterly revenue was up 6.6% compared to the same quarter last year. Genpact has set its FY 2025 guidance at 3.600-3.610 EPS and its Q4 2025 guidance at 0.930-0.940 EPS.  Analysts predict that  Genpact Limited will post 3.21 earnings per share for the current fiscal year. </p><h2>Genpact Announces Dividend</h2><ul><li>What’s on the Thanksgiving Table? A Stock Pick for Every Course</li></ul><p>The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 23rd. Stockholders of record on Tuesday, December 9th will be paid a dividend of $0.17 per share. The ex-dividend date is Tuesday, December 9th. This represents a $0.68 annualized dividend and a dividend yield of 1.5%. Genpact's dividend payout ratio  is 21.94%. </p><h2>Analysts Set New Price Targets</h2><p>A number of research firms have recently issued reports on G. Citigroup upgraded Genpact to a &#34;hold&#34; rating in a report on Thursday, October 23rd. JPMorgan Chase &amp; Co. reduced their price objective on Genpact from $55.00 to $50.00 and set a &#34;neutral&#34; rating for the company in a research note on Wednesday, August 20th. Needham &amp; Company LLC lifted their target price on Genpact from $50.00 to $53.00 and gave the company a &#34;buy&#34; rating in a research note on Friday, August 8th. Weiss Ratings  reiterated a &#34;hold (c)&#34; rating on shares of Genpact in a report on Wednesday, October 8th. Finally, Wall Street Zen upgraded shares of Genpact from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday, November 15th. Three analysts have rated the stock with a Buy rating and six have assigned  a Hold rating to the stock. According to MarketBeat.com, the company  has an average rating of &#34;Hold&#34; and an average price target of $51.13.</p><p><b>Get Our Latest Stock Analysis on Genpact</b></p><h2>About Genpact</h2> (Free Report)<p>Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.</p><h2>See Also</h2><ul><li>Five stocks we like better than Genpact</li><li>What is the Dogs of the Dow Strategy? Overview and Examples</li><li>The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy</li><li>Best Aerospace Stocks Investing </li><li>Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF</li><li>Value Investing: Is it a Good Strategy in 2022? <span>Hint: Always<span></span></span></li><li>Strong Quarter, Weak Reaction: Why GitLab Shares Dropped</li></ul><p><strong>Want to see what other hedge funds are holding G?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUc?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUc"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Genpact Right Now?</h2><p>Before you consider Genpact, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.</p><p>While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>New York State Common Retirement Fund increased its stake in Genpact Limited by 25.3% in Q2, owning 227,915 shares worth $10,031,000. Other institutional investors also adjusted their holdings. Genpact's CEO and SVP sold shares, reducing their positions. Genpact reported Q3 earnings of $0.97 per share, beating estimates, with revenue of $1.29 billion, up 6.6% year-over-year. The company has set FY 2025 EPS guidance at 3.600-3.610.</p>

Genpact Limited $G Holdings Raised by New York State Common Retirement Fund